Effect of high-dose vitamin D3on hospital length of stay in critically ill patients with vitamin D deficiency: The VITdAL-ICU randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 312, Issue 15, 2014, Pages 1520-1530

  Amrein, Karin ^a   Schnedl, Christian ^a   Holl, Alexander ^a   Riedl, Regina ^a   Christopher, Kenneth B ^b   Pachler, Christoph ^a   Purkart, Tadeja Urbanic ^a   Waltensdorfer, Andreas ^a   Münch, Andreas ^a   Warnkross, Helga ^a   Stojakovic, Tatjana ^a   Bisping, Egbert ^a   Toller, Wolfgang ^a   Smolle, Karl Heinz ^a   Berghold, Andrea ^a   Pieber, Thomas R ^a   Dobnig, Harald ^a,c  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Schilddrüsen Endokrinologie Osteoporose Institut Dobnig   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; PLACEBO; VITAMIN;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; LENGTH OF STAY; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL HEALTH; NUTRITIONAL STATUS; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; CONTROLLED CLINICAL TRIAL; CRITICAL ILLNESS; INTENSIVE CARE UNIT; MIDDLE AGED;

AGED; CHOLECALCIFEROL; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84908145123     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.13204     Document Type: Article

References (30)

1. Bjelakovic G, Gluud LL, Nikolova D, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2011;(7): CD007470.
2. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008; 168(12):1340-1349.
3. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: ameta-analysis of prospective cohort studies. Am J Clin Nutr. 2012;95(1):91-100.
4. Chowdhury R, Kunutsor S, Vitezova A, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014;348:g1903.
5. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014;348:g2035.
6. Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014;2 (4):307-320.
7. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2(1):76-89.
8. Lee P, Eisman JA, Center JR. Vitamin D deficiency in critically ill patients. N Engl J Med. 2009;360(18):1912-1914.
9. Perron RM, Lee P. Efficacy of high-dose vitamin D supplementation in the critically ill patients. Inflamm Allergy Drug Targets. 2013;12(4):273-281.
10. Braun AB, Litonjua AA, Moromizato T, Gibbons FK, Giovannucci E, Christopher KB. Association of low serum 25-hydroxyvitamin D levels and acute kidney injury in the critically ill. Crit Care Med. 2012; 40(12):3170-3179.
11. Moromizato T, Litonjua AA, Braun AB, Gibbons FK, Giovannucci E, Christopher KB. Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill. Crit Care Med. 2014;42(1):97-107.
12. HolickMF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281.
13. Amrein K, Sourij H,Wagner G, et al. Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study. Crit Care. 2011;15(2):R104.
14. Amrein K, Schnedl C, Berghold A, Pieber TR, Dobnig H. Correction of vitamin D deficiency in critically ill patients - VITdAL@ICU study protocol of a double-blind, placebo-controlled randomized clinical trial. BMC Endocr Disord. 2012;12(1):27.
15. World Medical Association. Declaration of Helsinki - ethical principles for medical research involving human subjects. http://www.wma.net/en /30publications/10policies/b3/. Accessed September 1, 2014.
16. Medical University of Graz. Randomizer. http: //www.randomizer.at/. Accessed September 17, 2014.
17. McNally JD. Vitamin D as a modifiable risk factor in critical illness: questions and answers provided by observational studies. J Pediatr (Rio J). 2014;90 (2):99-101.
18. Bacon CJ, Gamble GD, Horne AM, Scott MA, Reid IR. High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int. 2009;20(8):1407-1415.
19. von Restorff C, Bischoff-Ferrari HA, Theiler R. High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency. Bone. 2009;45(4):747-749.
20. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: Institute of Medicine; 2011.
21. Cluse ZN, Fudge AN, Whiting MJ, McWhinney B, Parkinson I, O'Loughlin PD. Evaluation of 25-hydroxy vitamin D assay on the immunodiagnostic systems iSYS analyser. Ann Clin Biochem. 2012;49(Pt 2):159-165.
22. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.
23. Fine J, Gray J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509. doi:10.1080/01621459.1999.10474144.
24. Mehlhorn J, Freytag A, Schmidt K, et al. Rehabilitation interventions for postintensive care syndrome: a systematic review. Crit Care Med. 2014;42(5):1263-1271.
25. Spriet I, Meersseman W, de Hoon J, von Winckelmann S, Wilmer A, Willems L. Mini-series: II: clinical aspects: clinically relevant CYP450-mediated drug interactions in the ICU. Intensive Care Med. 2009;35(4):603-612.
26. Michaud J, Naud J, Ouimet D, et al. Reduced hepatic synthesis of calcidiol in uremia. J AmSoc Nephrol. 2010;21(9):1488-1497.
27. Vieth R. Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr. 2006;136(4):1117-1122.
28. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303(18):1815-1822.
29. Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women - a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford). 2007;46(12):1852-1857.
30. Knox S, Harris J, Calton L,Wallace AM. A simple automated solid-phase extraction procedure for measurement of 25-hydroxyvitamin D3 and D2 by liquid chromatography-tandem mass spectrometry. Ann Clin Biochem. 2009;46(pt 3):226-230.